Daunorubicin or Idarubicin clinical trials

A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

This study is testing a new drug called Bleximenib alongside standard treatments for acute myeloid leukaemia (AML). It aims to find the safest and most effective dose of Bleximenib when given with other AML medicines, and to understand its side effects.